About ACINTA
ACINTA is a company founded in 2010. The company has 167 employees. ACINTA offers products and services including Ethical Pharmaceutical Specialties and Sales and Marketing Network.
- Employees 167
- SectorsHealthcare
- Email••••••••
- Legal Name Acinta Pharmaceuticals Pvt. Ltd
- Date of Incorporation 29 Mar, 2010
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹18.54 Cr
FY 2025 · +2% YoY
- Net Loss-₹1.14 Cr
FY 2025 · -6% margin
- EBITDA-₹1.14 Cr
FY 2025 · -6% margin
- Employee Count167
Associated legal entities of ACINTA
ACINTA operates through Acinta Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Acinta Pharmaceuticals Private Limited CIN U24233MH2010PTC201377 | Active | 29 Mar 2010 | Mumbai, Maharashtra | ₹18.5 Cr | 167 | 3 | View details |
Products & Services of ACINTA
ACINTA offers a comprehensive portfolio of products and services, including Ethical Pharmaceutical Specialties and Sales and Marketing Network.
High-quality ethical pharmaceutical specialties are manufactured and marketed using innovative technologies and cGMP standards.
A countrywide sales and marketing network is established to distribute pharmaceutical products through trained professionals.
Board of directors of Acinta Pharmaceuticals Private Limited (ACINTA)
Acinta Pharmaceuticals Private Limited is the primary company behind ACINTA. The board of Acinta Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Praveen Sharma, appointed in 2010. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Praveen Sharma DIN 00409273 | Director | 29 Mar 2010 | 16 yrs 6 mo | Acinta Pharmaceuticals Private Limited |
| Meenakshi Sharma DIN 00523884 | Director | 25 Jun 2012 | 14 yrs 3 mo | Acinta Pharmaceuticals Private Limited |
| Yash Sharma DIN 08508650 | Whole-time director | 23 Jul 2019 | 7 yrs 2 mo | Acinta Pharmaceuticals Private Limited |
Financials of ACINTA
Figures of Acinta Pharmaceuticals Private Limited, the primary company behind ACINTA, for FY 2025. Revenue was ₹18.54 Cr (+2% year on year). Net loss was -₹1.14 Cr (-6% margin). EBITDA was -₹1.14 Cr (-6% margin). Revenue has grown at a compounded annual rate of +9% over three years and +4% over five years.
- ₹18.54 CrRevenue · FY 2025 · +2% YoY
- -₹1.14 CrNet loss · -6% margin
- -₹1.14 CrEBITDA · -6% margin
- ₹1 LakhPaid-up capital
- 167Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Acinta Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for ACINTA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to ACINTA
10 companies that operate in the same segment as ACINTA (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ACINTA
ACINTA was founded in 2010.
ACINTA has 167 employees.
The primary company behind ACINTA, Acinta Pharmaceuticals Private Limited, reported revenue of ₹18.54 Cr for FY 2025, up 2% year on year.
ACINTA is identified as a market-oriented pharmaceutical company that manufactures and markets high-quality ethical pharmaceutical specialties. Innovative technologies and cGMP standards are utilized by ACINTA to ensure reliability and performance in Indian markets. Quality methodologies are followed to reduce time-to-market and maintain predictability in cost and quality. A countrywide sales network is being established through trained professionals, while people are considered the greatest asset for organizational success. Continuous updates to international standards are made to position ACINTA as a major player in the pharmaceutical world.
ACINTA offers Ethical Pharmaceutical Specialties and Sales and Marketing Network.
ACINTA operates through Acinta Pharmaceuticals Private Limited.
The legal entities of ACINTA currently have 3 directors, including Praveen Sharma, Meenakshi Sharma, Yash Sharma.